- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 209/30 - Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
Patent holdings for IPC class C07D 209/30
Total number of patents in this class: 316
10-year publication summary
|
27
|
23
|
13
|
21
|
18
|
23
|
15
|
13
|
26
|
4
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Achillion Pharmaceuticals, Inc. | 176 |
10 |
| UCB Pharma GmbH | 97 |
9 |
| F. Hoffmann-La Roche AG | 7958 |
8 |
| Cornell University | 3036 |
7 |
| Novita Pharmaceuticals, Inc. | 19 |
7 |
| Bristol-myers Squibb Company | 5080 |
6 |
| LG Chem, Ltd. | 17205 |
6 |
| Ono Pharmaceutical Co., Ltd. | 454 |
6 |
| Vanderbilt University | 1731 |
5 |
| AstraZeneca AB | 3042 |
4 |
| Vertex Pharmaceuticals Incorporated | 1581 |
4 |
| Kissei Pharmaceutical Co., Ltd. | 215 |
4 |
| Suven Life Sciences Limited | 129 |
4 |
| University of Tennessee Research Foundation | 727 |
4 |
| PolyPeptide Laboratories Holding (ppl) AB | 37 |
4 |
| Radius Pharmaceuticals, Inc. | 63 |
4 |
| Eisai R&D Management Co., Ltd. | 1304 |
4 |
| H. Lundbeck A/S | 1252 |
4 |
| Suzhou Mednes Pharma Tech Co., Ltd. | 4 |
4 |
| AstraZeneca UK Limited | 768 |
3 |
| Other owners | 209 |